In addition to changes in expression or location of AQP4 in neurological disorders, AQP4 is also implicated as a target in neuromyelitis optica (NMO) [32,33,34], an autoimmune disease characterized by inflammation and demyelination of the optic nerve, large spinal cord lesions, and the presence of NMO-IgG in serum [35]. Here, AQP4 is linked to nervous system disorder.